Alterations in Early Action
Key Words: heart failure Ⅲ excitation contraction coupling Ⅲ sarcoplasmic reticulum Ⅲ calcium transients H emodynamic overload induces cardiac hypertrophy and alterations in the contractile properties of the resident cardiac myocytes, both of which can help the heart maintain cardiac output. However, when the hemodynamic stress is persistent, the heart usually makes a transition from compensated hypertrophy to a progressively deteriorating functional state termed congestive heart failure (CHF). This transition is known to be associated with alterations in the magnitude, duration, and kinetics of the systolic Ca 2ϩ transient. Multiple cellular and molecular changes are thought to underlie the abnormal Ca 2ϩ transient of the hypertrophied/ failing myocyte. [1] [2] [3] [4] [5] [6] [7] The reduced size and prolonged duration of the Ca 2ϩ transient involves reduced sarcoplasmic reticulum (SR) Ca 2ϩ stores 1,7-9 resulting from a slowed rate of SR Ca 2ϩ uptake. This reduced SR function is thought to be caused by reductions in the density of the SR Ca 2ϩ ATPase (SERCA) 10 -12 and by reduced phosphorylation of the SERCA inhibitory protein phospholamban (PLB). [13] [14] [15] There is also some evidence for an increased rate of Ca 2ϩ "leak" from the SR through "hyperphosphorylated" Ca 2ϩ release channels (ryanodine receptors, RYR). 16, 17 Recently, it has been shown that in myocytes in the infarct border zone, the rate of rise of the Ca 2ϩ transient is slowed because SR Ca 2ϩ release from junctional SR is dyssynchronous. 18 In the normal cardiac myocyte, junctional release sites are located along each Z-line and these sites are triggered to synchronously release their Ca 2ϩ during the early portion of the action potential by Ca 2ϩ entry through the L-type Ca 2ϩ channel (LTCC). 19, 20 In normal myocytes, it appears that almost all SR storage sites release their Ca 2ϩ with each heart beat. 19 Spatially dyssynchronous SR Ca 2ϩ release would slow the rate of rise of the global cytosolic Ca 2ϩ transient in diseased myocytes. This type of deranged SR Ca 2ϩ release could result from fixed structural abnormalities including loss of T-tubules and/or junctional SR from some regions of the myocyte. 21, 22 An alternative explanation would be failure of some SR sites to release their stored Ca 2ϩ due to deranged excitation contraction (EC) coupling.
This study examined if SR Ca 2ϩ release is spatially and/or temporally dysynchronous in either hypertrophied or failing feline myocytes and then went on to examine the bases for the dysynchronous release. Confocal line scan imaging was used to study the synchrony of Ca 2ϩ release within single ventricular myocytes from feline hearts with left ventricular hypertrophy (LVH) induced by ascending aortic constriction (AC). AC induced two distinct phenotypes, concentric LVH or hypertrophy with dilatation and signs and symptoms of early CHF. Field stimulation-induced SR Ca 2ϩ release was significantly less synchronous in CHF versus normal and LVH myocytes. This dyssynchrony was associated with changes in the early repolarization phases of the AP and was eliminated by inducing maximal Ca 2ϩ influx through the LTCC with voltage clamp techniques. These results show that failure of a fraction of junctional SR sites to release their Ca 2ϩ contributes to the abnormal cytosolic Ca 2ϩ transients of failing myocytes. Dyssynchronous release appears to be due to alterations in Ca 2ϩ -induced SR Ca 2ϩ release rather than from loss of release units, making these abnormalities viable targets for CHF inotropic therapy.
Materials and Methods
LVH was induced by aortic constriction as described in detail previously. Before euthanasia, echocardiography was used to assess in vivo cardiac function. Myocytes were isolated using standard techniques. Ca 2ϩ transient were measured with line scan confocal imaging, and action potential and whole-cell currents were recorded with patch clamp techniques. Full details can be found in an expanded Materials and Methods section in the online data supplement available at http://circres.ahajournals.org.
Results

Characteristics of Pressure-Overloaded Hearts
Aortic constriction induced significant hypertrophy in all animals with two distinct structural and functional phenotypes. Representative echocardiographic analyses are shown in Figure 1A . Half of the banded animals (nϭ5) developed concentric LV hypertrophy (LVH) with significant increases in LV wall thickness and a small decrease in diastolic chamber dimensions. The remaining banded animals (nϭ5) developed LV dilatation (CHF) with thinner walls than the LVH group, but thicker than controls (nϭ5). There was a significant increase in the heart weight to body weight ratio (HW/BW ratio) in the LVH (7.79Ϯ0.93) and CHF groups (8.97Ϯ0.91) versus controls (4.10Ϯ0.45) ( Figure 1B) . CHF hearts had significant smaller fractional shortening (23.7Ϯ5.7%) versus LVH (50.5%Ϯ3.7) and controls (51.4%Ϯ1.63) ( Figure 1C ). CHF hearts also tended to have a greater diastolic diameter (1.58Ϯ.09 cm) versus control (1.31Ϯ0.11 cm) and LVH (1.28Ϯ.09 cm) groups ( Figure  1D ). CHF animals had shortness of breath with activity and ascites. This in vivo analysis suggests that baseline cardiac function is maintained in compensated LVH hearts and is depressed in those with dilatation and signs and symptoms of early heart failure.
Field Stimulation
Cytosolic Ca 2ϩ transients were measured with line scan confocal imaging in myocytes isolated from normal and hypertrophied hearts paced at 0.2 and 1.0 Hz. (Figure 2A ). Control myocytes had synchronous SR Ca 2ϩ release at all pacing rates, whereas SR Ca 2ϩ release in CHF myocytes was spatially and temporally less well organized. LVH myocytes had visually synchronous SR Ca 2ϩ release; however, the rate of rise of the global Ca 2ϩ transients (dCa 2ϩ /dt) decreased to the greatest extent in these myocytes when their stimulation rate was increased ( Figure 2B ).
The spatial uniformity (synchrony) of Ca 2ϩ release along the scan line was calculated as described in the expanded Materials and Methods. An example is shown in Figure 3A and spatial fluorescence profiles are shown in Figure 3B . The dotted lines (10 and 40 ms) represent the times chosen for analysis. At 10 ms, there are fewer regions of the cytosol with fluorescence above 50% of the peak value than at later times. Spatial uniformity occurred earlier in control versus LVH and CHF myocytes. This analysis showed that control (nϭ9) and LVH cells (nϭ15) had similar spatial synchrony at 0.2 Hz ( Figure 3C ), but Ca 2ϩ release became less well organized in LVH myocytes when the pacing rate was increased to 1.0 Hz. SR Ca 2ϩ release was significantly less synchronous in CHF (nϭ12) versus control and LVH myocytes at both 0.2 Hz and 1.0 Hz.
Decreases in the synchrony of SR Ca 2ϩ release was associated with slowing of dCa 2ϩ /dt ( Figure 3D ). At 0.2 Hz, dCa 2ϩ /dt was significantly slower in CHF versus control and LVH myocytes. Increasing the stimulation rate to 1.0 Hz caused dCa 2ϩ /dt to decrease significantly in both LVH and CHF but not in control myocytes.
The global peak systolic Ca 2ϩ (average fluorescence along the line scan) at 0.2 Hz was significantly smaller in CHF (nϭ12) versus control (nϭ9) and LVH (nϭ15) cells ( Figure  3E ). These results are consistent with our previous studies in which we measured whole-cell Ca 2ϩ transients with indo-1. 2 
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Bases of Abnormal Ca 2؉ Release in Heart Failure 545 At 1.0 Hz, the peak Ca 2ϩ was significantly greater in control myocytes versus LVH and CHF myocytes ( Figure 3E ).
Poorly organized SR Ca 2ϩ release could result from physical loss of release units (couplons), which we loosely term structural defects (loss of T-tubules or junctional SR) and/or failure of existing couplons to release Ca 2ϩ , which represent defective EC coupling. The local absence of SR Ca 2ϩ release resulting from the absence of a couplon should produce spatial Ca 2ϩ release profiles that are consistent from beat to beat, whereas those resulting from defective triggering of release should vary in time (from the stimulus) and location on a beat to beat basis. To evaluate these possibilities we measured local Ca 2ϩ release from specific sites within representative normal and CHF myocytes during consecutive field stimulated beats at 0.2 Hz (Figure 4 ). In the normal (control) myocyte, the spatial and temporal characteristics of local Ca 2ϩ transients were nearly identical in every beat ( Figure  4A ). A distinctly different pattern was observed in failing myocytes ( Figure 4B ). SR Ca 2ϩ release was spatially and temporally variable from beat to beat. Similar results were observed in all failing myocytes. These results strongly support the hypothesis that defects in EC coupling cause either delayed or intermittent loss of SR Ca 2ϩ release in feline CHF myocytes.
Voltage Clamp
To further test the idea that defects in EC coupling cause dyssynchronous SR Ca 2ϩ release in CHF, myocytes voltage clamp techniques were used to control and vary the magnitude of the triggering LTCC current (I Ca-L ). Line scan images from representative control and CHF myocyte at 0 and Ϯ30 mV are shown in Figure 5A . SR Ca 2ϩ release was not well synchronized at negative (Ϫ30 mV) and strongly positive voltages (ϩ30 mV) where Ca 2ϩ current is small (see later). Surprisingly, when the membrane potential was stepped to voltages that induce maximal I Ca-L (ϩ10 mV), SR Ca 2ϩ release was well organized in CHF myocytes ( Figure 5C ), even though the peak systolic [Ca 2ϩ ] was significantly smaller than in controls (Figure 5B and 5D ). These studies show that the spatial and temporal synchrony of SR Ca 2ϩ release varies with the amplitude of the initiating I Ca-L in all feline myocytes and that synchronous SR Ca 2ϩ release can be induced in CHF myocytes, supporting the hypothesis that the disorganized release they exhibit during field stimulation is caused by factors that influence EC coupling.
The uniformity of SR Ca 2ϩ release had a bell-shaped voltage dependence similar to the Ca 2ϩ current-voltage relationship ( Figure 5C ) in control and CHF myocytes. There were no differences in the uniformity of SR Ca 2ϩ release in CHF versus normal myocytes at potentials from 0 to ϩ60 mV. At negative test potentials (near Ϫ30 mV), SR Ca 2ϩ release was actually more uniform in CHF myocytes versus LVH and control (see Discussion). These results show that the differences in uniformity of SR Ca 2ϩ release observed in field stimulated CHF versus normal myocytes are eliminated when release synchrony is compared under voltage clamp conditions. Such findings support the idea that synchronization abnormalities in CHF myocytes are caused by alterations in factors regulating triggered release of SR Ca 2ϩ rather than from couplon loss. It is important to point out that the synchrony of SR Ca 2ϩ release is steeply voltage dependent between 0 to ϩ60 mV, with SR Ca 2ϩ release becoming less uniform at more positive membrane potentials.
SR Ca 2ϩ load was not measured directly in this study. However, its seems unlikely that it was significantly different in field stimulation and voltage clamp experiments given the fact that the induced Ca 2ϩ transients were identical within each myocyte group under these two experimental settings ( Figure 5D ). Therefore, dyssynchronous SR Ca 2ϩ release in field stimulated CHF myocytes might be caused by action potential alterations that reduce Ca 2ϩ influx and induce defective EC coupling.
Changing the density of Ca 2ϩ influx through LTCCs influences the efficacy of EC coupling and could contribute to the dyssynchronous SR Ca 2ϩ release we have observed. I Ca-L was measured in myocytes from normal, LVH, and CHF animals ( Figure 5E ). Similar to what we found in previous studies, 23 I Ca-L density was smaller in LVH versus controls, and there was evidence that T-type Ca 2ϩ current was present (see current at Ϫ30 mV) in LVH. I Ca-L density was further reduced in CHF. These experiments show that there is a progressive reduction of I Ca-L density in proportion to the severity of the hemodynamic stress. This reduction in Ca 2ϩ influx is likely to be involved in the reduced synchrony of SR Ca 2ϩ release in field stimulated CHF myocytes.
Action Potential Alterations in CHF Myocytes
The transient outward K ϩ current (I to ) is decreased in hypertrophied myocardium. 24, 25 In feline ventricular myocytes, I to is responsible for a phase of rapid repolarization (phase 1) before the plateau portion of the action potential (AP). It is during this time period that LTCCs activate and the subsequent Ca 2ϩ influx induces SR Ca 2ϩ release. 26 Reduction in I to should elevate the early portion of the AP to more positive potentials and, by reducing the electrochemical gradient, reduce the influx of trigger Ca 2ϩ . APs measured in both LVH and CHF myocytes had significantly smaller amounts of early repolarization ( Figure 6A ), consistent with reductions in I to . The average membrane potential at the base of the notch is significantly more positive in these hypertrophied myocytes versus control ( Figure 6B ).
To further explore the hypothesis that differences in the voltage profile of the AP plateau phase influence the uniformity of SR Ca 2ϩ release, control myocytes were voltage clamped with AP (so called AP voltage clamp) profiles with either a normal or CHF (no phase 1 notch) wave shape ( Figure 7A ). In these experiments, AP clamp was preceded with five square wave voltage steps (250 ms) from Ϫ70 to ϩ10 mV to provide uniform loading of the SR before the test AP clamp profiles. Figure 7A shows that when a control myocyte was clamped with a normal AP profile having the early phase 1 repolarization notch (left), there was uniform Ca 2ϩ release. However, when a CHF AP profile without early rapid phase 1 repolarization was used, Ca 2ϩ release was dyssynchronous. This dyssynchrony caused a slowing in the rate of rise of the Ca 2ϩ transient and a loss of spatial and temporal release uniformity ( Figure 7B ). Similar results were obtained in five other control myocytes.
Discussion
Depressed basal contractility and reduced contractility reserve in heart failure are largely caused by a slowing of the rate of rise and a decrease in the magnitude of the systolic Ca 2ϩ transient. 27 The objective of the present study was to determine whether alterations in the synchrony (uniformity) of SR Ca 2ϩ release from the junctional SR contributes to defective Ca 2ϩ regulation in CHF in either LVH or CHF myocytes. The major findings of our experiments were as follows: (1) 
EC Coupling in Ventricular Myocytes
EC coupling in cardiac myocytes starts during the upstroke of the action potential, which causes the opening of LTCCs. The subsequent influx of Ca 2ϩ elevates its subsarcolemmal concentration, which promotes binding to and opening of RYRs and initiates locally regenerative SR Ca 2ϩ release. This process occurs at the t-tubule-SR junction (local control hypothesis), 28 and this region has been called the couplon. 29 Normal contraction requires that SR Ca 2ϩ release is coordinated within the cell. A recent study in normal ventricular myocytes 19 showed that all regions of the junctional SR release their Ca 2ϩ with each AP, producing a uniform Ca 2ϩ activation wavefront. Because only a fraction of LTCCs open with each depolarization, 30 a sufficient number of channels must be present at each couplon to ensure a high "safety factor" for release in normal myocytes. In the present study, we demonstrate that in hypertrophied/failing feline myocytes there is intermittent failure or a large temporal delay of Ca 2ϩ release from individual couplons, leading to a break down in the uniformity of SR Ca 2ϩ release.
I Ca2؉ Amplitude Synchronizes SR Ca 2؉ Release
Our experiments suggest that local failure of EC coupling at individual couplons desynchronizes SR Ca 2ϩ release and contributes to the slowly rising, slowly decaying Ca 2ϩ transients of the CHF myocyte. These local release abnormalities can be rescued by optimizing Ca 2ϩ influx through the LTCC, proving that the absence of release units (structural abnormalities) 21 is not the cause of dyssynchrony.
EC coupling defects that spatially and temporally desynchronize SR Ca 2ϩ release are likely to involve changes in the number, properties, and localization of LTCCs and RYR within the junctional complex. Importantly, there is always some temporal variability in normal SR Ca 2ϩ release. This normal temporal variability cannot be well resolved with the techniques used in the present experiments, and the temporal delays we have observed are well beyond those predicted by the properties of single LTCC in normal myocytes. 30 The time between depolarization and triggered release of Ca 2ϩ from the junctional SR is determined by factors including the number of LTCCs within the couplon, LTCC properties, the morphology of the diffusion limiting space in which Ca 2ϩ accumulates, the Ca 2ϩ buffering within this space, the number of RYRs per couplon, and RYR properties. Alterations in any or all of these could produce the temporal delays and local failure of SR release we observed. However, little is known about many of these factors. We have shown that the density of LTCCs is reduced in LVH and further reduced in CHF myocytes. We speculate that this results in a decrease in the number of LTCCs per couplon that would increase temporal variability and reduce the safety factor for release. The positive voltage shift in the early portion of the AP that we have observed would also reduce Ca 2ϩ influx and should contribute to EC coupling defects. Our results suggest that a decreased LTCC density within the couplon and decreased Ca 2ϩ flux through open channels (due to the AP alterations) produce a reduction in local submembrane Ca 2ϩ , which is sufficient to cause intermittent localized failure of SR Ca 2ϩ release. Importantly, our results show that there are a sufficient number of LTCCs per couplon in CHF myocytes to cause well-synchronized release, as evidenced by our voltage clamp studies. Our results are consistent with the hypothesis that the EC coupling safety factor is reduced in diseased myocytes and that this can lead to the release dyssynchrony we have observed.
Alterations in the relationships between Ca 2ϩ influx and SR Ca 2ϩ release (termed EC coupling "gain") is one possible explanation for our results. 31 We did not compute this parameter because I Ca-L density cannot be measured accurately with the conditions we used to study SR Ca 2ϩ release. Our voltage clamp experiments show that when the membrane voltage is changed to potentials where maximal I Ca-L is induced (0 to ϩ10 mV), synchronous SR Ca 2ϩ release occurs in all myocytes ( Figure 5) We cannot infer the properties (opening probability) of LTCCs in failing feline myocytes from the present data. We and others 32, 33 have shown that the phosphorylation state of the LTCC is likely to be increased in the failing cells. Our finding that the voltage dependence of SR Ca 2ϩ release is shifted to negative potentials in failing myocytes is consistent with the effect of PKA-mediated phosphorylation on the voltage dependence of LTCC activation. 34, 35 However, we did not see this leftward shift in the voltage dependence of I Ca-L activation when it was directly measured ( Figure 5E ).
AP Alterations Lead to EC Coupling Defects
Changes in AP wave shape of hypertrophied/failing ventricular myocytes have been studied in large and small animal models and in humans. 36 Although there are fundamental differences in the molecular bases of the AP in large and small mammals, 37 there some changes in AP morphology with hypertrophy and failure that are consistently observed in all species. Hypertrophy and failure are associated with prolongation of the QT interval, which results from a prolongation of the AP duration. 38 The ion channels density that changes most consistently among species in hypertrophy and failure is I to . 24 This is the current that controls the rapid repolarization of the AP in small mammals (rats and mice) and the early repolarizing phase of the AP in large mammals (felines and humans). Reduction in I to is likely to be responsible for the loss of early repolarization and the associated EC coupling defects we observed in failing myocytes. The channel responsible for I to does not fully recover from inactivation at faster pacing frequencies, resulting in frequency-dependent loss of the early repolarization. We speculate that this could contribute to frequency-dependent EC coupling defects and the negative force frequency relationships in failing myocardium. 39 
Ca
2؉ Regulation in Heart Failure
In failing myocardium, the Ca 2ϩ transient has a smaller than normal peak amplitude (at fast heart rates), a slower rate of rise, and a prolonged duration. 1, 6, 40, 41 Alterations in SR Ca 2ϩ uptake, storage, and release are contributing factors. 42 SR abnormalities are thought to be caused by reduced SERCA2 abundance, 10 -12 decreases in PLB phosphorylation [13] [14] [15] and "hyperphosphorylation" of the RYR 16 with an associated increase in the SR Ca 2ϩ leak rate. In addition, increased Na ϩ /Ca 2ϩ exchanger activity and elevated cell [Na ϩ ] i have been observed in failing myocytes 43, 44 and these cause abnormalities in both systolic and diastolic Ca 2ϩ . These changes in Ca 2ϩ regulation in hypertrophied/failing myocytes lead to a reduction in the amount of Ca 2ϩ stored in and released from the SR. 9, 45 We have previously shown that SR Ca 2ϩ stores are reduced in failing human myocytes 7 and the results of the present experiments (reduced peak Ca 2ϩ under all conditions) strongly support the hypothesis that SR Ca 2ϩ stores are smaller than normal in hypertrophied/failing feline myocytes. Although reduced SR Ca 2ϩ stores can explain the reduced amplitude of the Ca 2ϩ transient we observed, this abnormality does not appear to be the critical factor that intermittently causes a disorganized pattern of SR Ca 2ϩ release in field stimulated myocytes.
Summary
The present study suggests that EC coupling defects contribute to abnormal Ca 2ϩ transients of failing feline myocytes by decreasing the uniformity of local SR Ca 2ϩ release. The fact that these defects can be rescued by optimizing Ca 2ϩ influx through the LTCC shows that factors governing Ca 2ϩ release within existing couplons rather than loss of couplons are responsible for disorganized SR Ca 2ϩ release in CHF. Reduced I Ca-L density and the electrochemical driving force for Ca 2ϩ entry (due to loss of phase 1 repolarization) appear to underlie these EC coupling abnormalities. Therapies that target these fundamental defects should help correct the defective contractility of the failing heart.
